| Description | 1. Tussilagone inhibits dendritic cell function through the induction of heme oxygenase-1. 2. Tussilagone has anti-cancer activity, might be a potential chemotherapeutic agent for the prevention and treatment of human colon cancer. 3. Tussilagone has anti-oxidant and anti-inflammatory activities, may be an effective oxygenase-1 inducer and a valuable compound for modulating inflammatory conditions. 4. Tussilagone has potential treatment of neuro-inflammatory diseases through the inhibition of overproduction of nitric oxide and prostaglandin E(2) . |
| molecular weight | 390.51 |
| Molecular formula | C23H34O5 |
| CAS | 104012-37-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 71 mg/mL (181.8 mM) Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble |
| References | 1. Li H , Lee H J , Ahn Y H , et al. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of β-catenin[J]. Biochemical and Biophysical Research Communications, 2014, 443(1):132-137. |